Bayer (BAYN) Stock Forecast & Price Target

Compare

801 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

BAYN Analyst Ratings

Moderate Buy

5 Buy

7 Hold

0 Sell

Based on 12 analysts giving stock ratings to

Bayer

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

BAYN Stock 12 Month Forecast

Average Price Target

€31.26

▼(-6.13% Downside)

Based on 12 Wall Street analysts offering 12 month price targets for Bayer in the last 3 months. The average price target is €31.26 with a high forecast of €40.00 and a low forecast of €23.00. The average price target represents a -6.13% change from the last price of €33.30.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"18":"€18","41":"€41","23.75":"€23.8","29.5":"€29.5","35.25":"€35.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":40,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€40.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":31.26,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€31.26</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":23,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€23.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[18,23.75,29.5,35.25,41],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,30.47,31.20307692307692,31.936153846153847,32.669230769230765,33.402307692307694,34.135384615384616,34.86846153846154,35.60153846153846,36.33461538461538,37.067692307692305,37.800769230769234,38.533846153846156,39.26692307692308,{"y":40,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,30.47,30.53076923076923,30.591538461538462,30.65230769230769,30.713076923076922,30.773846153846154,30.834615384615386,30.895384615384614,30.956153846153846,31.016923076923078,31.07769230769231,31.138461538461538,31.19923076923077,{"y":31.26,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,30.47,29.895384615384614,29.32076923076923,28.746153846153845,28.17153846153846,27.596923076923076,27.02230769230769,26.447692307692307,25.873076923076923,25.298461538461538,24.723846153846154,24.14923076923077,23.574615384615385,{"y":23,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":19.193,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.221,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.536,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":22.601,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.208,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.03,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.14,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.46,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.12,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.86,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.64,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.95,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.47,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€40.00

Average Price Target€31.26

Lowest Price Target€23.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Thibault Boutherin

Morgan Stanley

€29→€40

Buy

20.12%

Upside

Upgraded

12/03/25

Bayer upgraded to Overweight from Equal Weight at Morgan StanleyBayer upgraded to Overweight from Equal Weight at Morgan Stanley

Charles Pitman CFA

Barclays

€30

Hold

-9.91%

Downside

Reiterated

12/02/25

Barclays Reaffirms Their Hold Rating on Bayer (0P6S)

Matthew Weston

UBS

€26→€32

Hold

-3.90%

Downside

Reiterated

12/02/25

Bayer (0P6S) Receives a Hold from UBS

Christian Faitz

Kepler Capital

€35

Buy

5.11%

Upside

Reiterated

12/02/25

Kepler Capital Sticks to Their Buy Rating for Bayer (0P6S)

Peter Spengler

DZ BANK AG

―

Buy

―

Reiterated

12/02/25

Bayer (0P6S) Receives a Buy from DZ BANK AG

Richard Vosser

J.P. Morgan

€25

Hold

-24.92%

Downside

Reiterated

12/02/25

Bayer (0P6S) Gets a Hold from J.P. Morgan

Sachin Jain

Bank of America Securities

€35

Buy

5.11%

Upside

Reiterated

12/02/25

Bank of America Securities Keeps Their Buy Rating on Bayer (0P6S)

Chris Counihan

Jefferies

€25

Hold

-24.92%

Downside

Reiterated

12/02/25

Jefferies Reaffirms Their Hold Rating on Bayer (0P6S)

James Quigley

Goldman Sachs

€38.5

Buy

15.62%

Upside

Reiterated

12/02/25

Bayer (0P6S) Gets a Buy from Goldman Sachs

Florent Cespedes

Bernstein

€30

Hold

-9.91%

Downside

Reiterated

11/24/25

Bernstein Sticks to Its Hold Rating for Bayer (0P6S)

Sebastian Bray

Berenberg Bank

€26→€30.4

Hold

-8.71%

Downside

Reiterated

11/13/25

Falko Friedrichs

Deutsche Bank

€23

Hold

-30.93%

Downside

Reiterated

11/12/25

Deutsche Bank Reaffirms Their Hold Rating on Bayer (0P6S)

Rajesh Kumar

HSBC

€20→€32

Buy

-3.90%

Downside

Upgraded

06/11/25

Bayer upgraded to Buy from Hold at HSBCBayer upgraded to Buy from Hold at HSBC

Andreas Heine

Stifel Nicolaus

€28

Hold

-15.92%

Downside

Reiterated

03/05/25

Bayer's Financial Challenges and Mixed Divisional Performance Lead to Hold Rating

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Thibault Boutherin

Morgan Stanley

€29→€40

Buy

20.12%

Upside

Upgraded

12/03/25

Bayer upgraded to Overweight from Equal Weight at Morgan StanleyBayer upgraded to Overweight from Equal Weight at Morgan Stanley

Charles Pitman CFA

Barclays

€30

Hold

-9.91%

Downside

Reiterated

12/02/25

Barclays Reaffirms Their Hold Rating on Bayer (0P6S)

Matthew Weston

UBS

€26→€32

Hold

-3.90%

Downside

Reiterated

12/02/25

Bayer (0P6S) Receives a Hold from UBS

Christian Faitz

Kepler Capital

€35

Buy

5.11%

Upside

Reiterated

12/02/25

Kepler Capital Sticks to Their Buy Rating for Bayer (0P6S)

Peter Spengler

DZ BANK AG

―

Buy

―

Reiterated

12/02/25

Bayer (0P6S) Receives a Buy from DZ BANK AG

Richard Vosser

J.P. Morgan

€25

Hold

-24.92%

Downside

Reiterated

12/02/25

Bayer (0P6S) Gets a Hold from J.P. Morgan

Sachin Jain

Bank of America Securities

€35

Buy

5.11%

Upside

Reiterated

12/02/25

Bank of America Securities Keeps Their Buy Rating on Bayer (0P6S)

Chris Counihan

Jefferies

€25

Hold

-24.92%

Downside

Reiterated

12/02/25

Jefferies Reaffirms Their Hold Rating on Bayer (0P6S)

James Quigley

Goldman Sachs

€38.5

Buy

15.62%

Upside

Reiterated

12/02/25

Bayer (0P6S) Gets a Buy from Goldman Sachs

Florent Cespedes

Bernstein

€30

Hold

-9.91%

Downside

Reiterated

11/24/25

Bernstein Sticks to Its Hold Rating for Bayer (0P6S)

Sebastian Bray

Berenberg Bank

€26→€30.4

Hold

-8.71%

Downside

Reiterated

11/13/25

Falko Friedrichs

Deutsche Bank

€23

Hold

-30.93%

Downside

Reiterated

11/12/25

Deutsche Bank Reaffirms Their Hold Rating on Bayer (0P6S)

Rajesh Kumar

HSBC

€20→€32

Buy

-3.90%

Downside

Upgraded

06/11/25

Bayer upgraded to Buy from Hold at HSBCBayer upgraded to Buy from Hold at HSBC

Andreas Heine

Stifel Nicolaus

€28

Hold

-15.92%

Downside

Reiterated

03/05/25

Bayer's Financial Challenges and Mixed Divisional Performance Lead to Hold Rating

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Bayer

1 Month

xxx

Success Rate

13/23 ratings generated profit

Average Return

+1.17%

reiterated a xxx

rating 7 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 56.52% of your transactions generating a profit, with an average return of +1.17% per trade.

3 Months

xxx

Success Rate

16/23 ratings generated profit

Average Return

+3.03%

reiterated a xxx

rating 7 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 69.57% of your transactions generating a profit, with an average return of +3.03% per trade.

1 Year

James QuigleyGoldman Sachs

Success Rate

16/23 ratings generated profit

Average Return

+8.33%

reiterated a buy rating 7 days ago

Copying James Quigley's trades and holding each position for 1 Year would result in 69.57% of your transactions generating a profit, with an average return of +8.33% per trade.

2 Years

xxx

Success Rate

16/23 ratings generated profit

Average Return

+6.09%

reiterated a xxx

rating 7 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 69.57% of your transactions generating a profit, with an average return of +6.09% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BAYN Analyst Recommendation Trends

Rating

Aug 25

Sep 25

Oct 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, BAYN has received 13 Buy Ratings, 22 Hold Ratings, and 0 Sell Ratings. BAYN average Analyst price target in the past 3 months is 31.26.

Each month's total comprises the sum of three months' worth of ratings.

BAYN Financial Forecast

BAYN Earnings Forecast

Next quarter’s earnings estimate for BAYN is €0.32 with a range of -€0.25 to €0.53. The previous quarter’s EPS was €0.57. BAYN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year BAYN has Performed in-line its overall industry.

BAYN Sales Forecast

Next quarter’s sales forecast for BAYN is €11.11B with a range of €10.65B to €11.29B. The previous quarter’s sales results were €9.66B. BAYN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year BAYN has Performed in-line its overall industry.

BAYN Stock Forecast FAQ

What is DE:BAYN’s average 12-month price target, according to analysts?

Based on analyst ratings, Bayer’s 12-month average price target is 31.26.

What is DE:BAYN’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for DE:BAYN, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Bayer a Buy, Sell or Hold?

Bayer has a consensus rating of Moderate Buy, which is based on 5 buy ratings, 7 hold ratings and 0 sell ratings.

What is Bayer’s share price target?

The average share price target for Bayer is 31.26. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €40.00 ,and the lowest forecast is €23.00. The average share price target represents -6.13% Decrease from the current price of €33.3.

What do analysts say about Bayer?

Bayer’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of Bayer?

To buy shares of DE:BAYN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Bayer (BAYN) Stock Forecast & Price Target

BAYN Analyst Ratings

BAYN Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Bayer

BAYN Analyst Recommendation Trends

BAYN Financial Forecast

BAYN Earnings Forecast

BAYN Sales Forecast

BAYN Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts